News Medical9h
Menarini Group signs licensing deal with Insilico for promising cancer treatment
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors
Shares of Quest Diagnostics Inc. DGX shed 1.45% to $151.79 Friday, on what proved to be an all-around dismal trading session ...
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill ...
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, ...
Quest Diagnostics Inc. stock rises Monday, still underperforms market
Shares of Quest Diagnostics Inc. DGX inched 0.23% higher to $152.27 Monday, on what proved to be an all-around mixed trading ...
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and ...